ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Ishita Drugs approved Rs.11.75 Crore borrowings from HDFC Bank, covering a term loan and working capital facility. This is within shareholder-approved borrowing limits from its 31st AGM.
Ishita Drugs & Industries Ltd will hold a board meeting on September 22, 2026. The meeting will consider raising funds through working capital and term loans.
Ishita Drugs & Industries Ltd has issued physical letters to shareholders with weblinks for its FY 2025-26 Annual Report. The 33rd AGM is scheduled for September 30, 2026.
Ishita Drugs & Industries Ltd has scheduled its 33rd Annual General Meeting for September 30, 2026. The book closure is set from September 24 to September 30, 2026.
Ishita Drugs and Industries Limited has re-appointed Abha Agrawal as a Non-Executive Non-Independent Director, effective October 1, 2026.
Ishita Drugs & Industries Ltd reported revenue from operations of ₹3.1 Cr (-42.6% YoY) and net profit of ₹0.2 Cr (-33.3% YoY) for Q1 FY27.